Company: BIVIW
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001520138-25-000166
Chunk: 7

Company: BIOVIE INC.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 7
---
<div align='center'>https://www.westcoaststocktransfer.com/proxy-bivi/</div>

Who is entitled to vote at the Special Meeting?

Only stockholders of record at the close of business
on June 2, 2025 (the “Record Date”), are entitled to vote at the Special Meeting. On the Record Date, there were shares of
BioVie’s common stock outstanding and entitled to vote. Each share of common stock is entitled to one vote on each matter properly
brought before the Special Meeting.

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

If on June 2, 2025 your shares were registered directly
in your name with BioVie’s transfer agent, West Coast Stock Transfer, Inc., then you are the “stockholder of record.”
Whether or not you plan to participate in the Special Meeting, we urge you to fill out and return the enclosed proxy card or vote via
the Internet or by telephone to ensure your vote is counted.

If on June 2, 2025 your shares were held in a stock
brokerage account or by a bank or other similar organization, then you are considered the “beneficial owner” of those shares.
These proxy materials have been forwarded to you by that organization. The organization holding your account is considered the stockholder
of record for purposes of voting at the Special Meeting. As the beneficial owner, you have the right to direct your broker, bank or other
agent how to vote the shares in your account. You are also invited to participate in the Special Meeting. However, because you are not
the stockholder of record, you may not vote your shares online at the virtual Special Meeting unless you request and obtain a valid proxy
from your broker, bank or other agent.

<div align='center'>-4-</div>

What am I voting on?

There are two matters scheduled for a vote:

| 1. | To grant the Board of Directors authority, in its sole discretion, prior to the one-year anniversary of this Special Meeting, to effect 
 a reverse stock split of the outstanding shares of the Company’s common stock, at a reverse split ratio of between 1-for-5 and 1-for-10 
 as determined by the Board of Directors, whereby every 5 to 10 shares of the authorized, issued and outstanding Common Stock shall be   
 combined into one (1) share of authorized, issued and outstanding Common Stock (the “Proposal 1